Accessibility Menu
 
Biofrontera logo

Biofrontera

(NASDAQ) BFRI

Current Price$0.82
Market Cap$9.59M
Since IPO (2021)-99%
5 YearN/A
1 Year-9%
1 Month-5%

Biofrontera Financials at a Glance

Market Cap

$9.59M

Revenue (TTM)

$41.71M

Net Income (TTM)

$10.54M

EPS (TTM)

$-1.18

P/E Ratio

-0.70

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.82

Volume

0

Open

$0.81

Previous Close

$0.82

Daily Range

$0.81 - $0.82

52-Week Range

$0.54 - $1.19

BFRI: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biofrontera

Industry

Pharmaceuticals

Employees

92

CEO

Hermann Lübbert, PhD

Headquarters

Woburn, MA 01801, US

BFRI Financials

Key Financial Metrics (TTM)

Gross Margin

76%

Operating Margin

-27%

Net Income Margin

-25%

Return on Equity

-141%

Return on Capital

-68%

Return on Assets

-37%

Earnings Yield

-1.43%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.59M

Shares Outstanding

11.65M

Volume

0

Short Interest

0.00%

Avg. Volume

478.00K

Financials (TTM)

Gross Profit

$31.59M

Operating Income

$11.35M

EBITDA

$10.48M

Operating Cash Flow

$13.36M

Capital Expenditure

$2.00K

Free Cash Flow

$13.36M

Cash & ST Invst.

$6.39M

Total Debt

$6.16M

Biofrontera Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$17.10M

+36.2%

Gross Profit

$14.37M

+97.1%

Gross Margin

84.01%

N/A

Market Cap

$9.59M

N/A

Market Cap/Employee

$104.27K

N/A

Employees

92

N/A

Net Income

$5.64M

+504.0%

EBITDA

$4.78M

+525.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$231.00K

-76.7%

Accounts Receivable

$7.29M

+37.2%

Inventory

$1.43M

-78.5%

Long Term Debt

$5.83M

+33.3%

Short Term Debt

$332.00K

-39.4%

Return on Assets

-36.89%

N/A

Return on Invested Capital

-68.07%

N/A

Free Cash Flow

$2.38M

-133.3%

Operating Cash Flow

$2.38M

-133.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
COCPCocrystal Pharma, Inc.
$1.05-2.78%
EVGNEvogene Ltd.
$0.85+0.85%
IMNNImunon, Inc.
$2.82+1.44%
GELSGelteq Limited Ordinary Shares
$0.72-3.28%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$44.39+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.18+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$76.96-0.02%
ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF
$16.41+0.03%

Questions About BFRI

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.